PAR — Par Drugs and Chemicals Balance Sheet
0.000.00%
- IN₹1.10bn
- IN₹763.08m
- IN₹1.01bn
- 78
- 85
- 25
- 72
Annual balance sheet for Par Drugs and Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | — | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 212 | 162 | 222 | 367 | 276 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 125 | 217 | 212 | 185 | 211 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 412 | 436 | 494 | 596 | 549 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 344 | 344 | 387 | 413 | 389 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 764 | 787 | 889 | 1,016 | 1,194 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 160 | 149 | 140 | 124 | 166 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 242 | 188 | 176 | 160 | 204 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 522 | 599 | 712 | 856 | 990 |
| Total Liabilities & Shareholders' Equity | 764 | 787 | 889 | 1,016 | 1,194 |
| Total Common Shares Outstanding |